Pediatric Blood Cancer Research Innovation Grant
Canadian researchers are invited to submit proposals to The Leukemia & Lymphoma Society of Canada (LLSC)'s Pediatric Blood Cancer Research Innovation Grant competition. This grant is designed to provide funding up to a maximum of $100,000 per year for two years.
The intent of this funding opportunity is to advance foundational scientific knowledge that can lead to future breakthroughs in understanding disease mechanisms and identifying novel therapeutic targets in all pediatric blood cancers, including rarer subtypes.
- Call for Proposals - November 2, 2026
- Letter of Intent (LOI) deadline - December 3, 2026, 4 pm ET
- Notification of Full Application invite - December 2026
- Full Application deadline - February 10, 2027, 4 pm ET
- Review Panel Meeting - May 2027
- Notification of Awards - Fall 2027
- Award Start Date - Nov 1, 2027
The application process will occur in two phases:
Phase I - Submission and consideration of a Letter of Intent (LOI).
Phase II - Invitation to submit a Full Application.
Both the Letter of Intent and the Full Application must be submitted electronically to the LLSC Research Grants portal through Proposal Central. (You must have an account on Proposal Central and be logged in.)
Applicants are welcome to contact us about eligibility or any other questions about the grant.
Funds for competitive applications will be awarded on the basis of scientific merit, using a priority rating system.